Viewing Study NCT05595460

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-14 @ 8:20 AM
Study NCT ID: NCT05595460
Status: RECRUITING
Last Update Posted: 2025-08-12
First Post: 2022-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Sponsor: RayzeBio, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None SCLC,Extensive Stage View
Keywords:

Keywords

Keyword Brief Keyword Text View
None actinium View
None alpha-emitter View
None SSTR+ ES-SCLC View
None SCLC View
None ES-SCLC View
None RYZ101 View
None 225Ac View
None 225Ac-DOTATATE View
None targeted radiotherapy View
None atezolizumab View
None carboplatin View
None etoposide View
None radiopharmaceutical View